ADIPOL® is indicated for the dietary prevention of the onset, recurrence and neoplastic progression of intestinal polyps (colon adenomas) in familial and sporadic colon adenopolyposis patients undergoing screening colonoscopy programs.  ADIPOL may also help subjects with long lasting, extensive and active intestinal inflammation, a known risk factor for the development of colon polyps and neoplasia, as per Irritable Bowel Disease, Crohn’s disease and ulcerative colitis. Adipol is also available under the registered name Eviendep® and is available for licensing.

Either alone, or in co-operation with others we have a number of products available for immediate license. Contact us to discuss territories and rights.